PET imaging of zirconium-89 labelled cetuximab: A phase I trial in patients with head and neck and lung cancer-Reference-Cited by-同舟云学术

PET imaging of zirconium-89 labelled cetuximab: A phase I trial in patients with head and neck and lung cancer

Published:2017-02 Issue:2 Volume:122 Page:267-273
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

van Loon Judith,Even Aniek J.G.,Aerts Hugo J.W.L.,Öllers Michel,Hoebers Frank,van Elmpt Wouter,Dubois Ludwig,Dingemans Anne-Marie C.,Lalisang Roy I.,Kempers Pascal,Brans Boudewijn,Winnepenninckx Véronique,Speel Ernst-Jan,Thunnissen Eric,Smits Kim M.,Boellaard Ronald,Vugts Danielle J.,De Ruysscher Dirk,Lambin Philippe

Funder

CTMM

EU 6th and 7th framework program

Interreg

Kankeronderzoekfonds Limburg

National Institute of Health

Dutch Cancer Society

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference33 articles.

1. The erbB family: targets for therapeutic development against cancer and therapeutic strategies using monoclonal antibodies and tyrosine kinase inhibitors;Rowinsky;Annu Rev Med,2004

2. Review of epidermal growth factor receptor biology;Herbst;Int J Radiat Oncol Biol Phys,2004

3. Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma;Ang;Cancer Res,2002

4. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck;Bonner;N Engl J Med,2006

5. Concomitant platinum-based chemotherapy or cetuximab with radiotherapy for locally advanced head and neck cancer: a systematic review and meta-analysis of published studies;Petrelli;Oral Oncol,2014

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted radionuclide therapy for head and neck squamous cell carcinoma: a review;Frontiers in Oncology;2024-08-22

2. ImmunoPET Targeting Receptor Tyrosine Kinase: Clinical Applications;Cancers;2023-12-18

3. Urokinase-Type Plasminogen Activator Receptor (uPAR) Expression and [64Cu]Cu-DOTA-AE105 uPAR-PET/CT in Patient-Derived Xenograft Models of Oral Squamous Cell Carcinoma;Molecular Imaging and Biology;2023-09-25

4. PET/CT in Patients with Breast Cancer Treated with Immunotherapy;Cancers;2023-05-05

5. First-, Second-, and Third-Generation Radiolabeled Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Positron Emission Tomography: State of the Art, a Systematic Review;Cancer Biotherapy and Radiopharmaceuticals;2023-05-01